(Last updated : 2024-10-24 10:04:03)
  Hideaki Kaneto
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of Diabetes, Endocrinology and Metabolism,
   Position   Professor
■ Journal
1. 2024/08 Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia 
2. 2024/07 C-peptide index at 2 hour after meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes 
3. 2024/07 Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching 
4. 2024/07 The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus 
5. 2024/06 Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice 
Display all(218)
■ Presentation
1. 2024/09/11 Elucidation of a new mechanism of action of GLP-1 focusing on pancreatic islet blood flow - Investigation by in vivo imaging - (口頭,一般) 
2. 2023/06/24 DPP-4 inhibitor and SGLT2 inhibitor additively ameliorate hepatic steatosis in NAFLD model mice through different action mechanisms (ポスター掲示,一般) 
3. 2023/06/24 GLP-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes ~Randomized, parallel-group, multicenter, open-label trial~ (ポスター掲示,一般) 
4. 2023/06/24 Protective effects of DPP-4 inhibitor and SGLT2 inhibitor on pancreatic β-cell function: Randomized, parallel-group, multicenter, open-label study (SECRETE-I) (ポスター掲示,一般) 
5. 2018/06/25 Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic beta cells in obese diabetic db/db mice - ‘‘The earlier and longer, the better’’ (ポスター掲示,一般) 
Display all(16)